FinksDaily
📊 Credit reckoning
Good morning. There’s a version of applying to college where you do nothing and still get in (opens in a new tab). That’s what’s happening at hundreds of campuses running “direct admissions,” where a transcript alone lands a formal offer letter. No essays, no test scores, no mailbox anxiety. It makes sense when you realize 70%+ of four-year nonprofit colleges already accept most applicants, so schools decided to skip the paperwork altogether. It’s starting to feel a lot like getting matched on a dating app — but swiping right on this platform comes with a tuition bill attached.
Top Idea
Healthcare Is Becoming Wall Street’s Ultimate Two-Way Trade
Healthcare is finally getting its turn under Wall Street’s spotlight. Investors are rotating toward the sector as tech enthusiasm gets bumpier and earnings visibility becomes more valuable. That combination is drawing both investors looking for shelter and those who still want room for upside.
Finding balance: Healthcare’s rally is running on both blockbusters and breakthroughs. Defensive giants and growthier biotech names are moving higher together, fueled by GLP-1 drugs, progress in cancer treatments, and a pickup in takeover activity. Valuations and dividends add to the appeal, while healthcare earnings are expected to jump 22% (opens in a new tab) next year versus ~15% for the S&P 500. Roth’s JC O’Hara called healthcare the “best of both worlds.”
- The Health Care Select Sector SPDR ETF has climbed 17% in three months, far ahead of the S&P 500’s 2.5% gain.
- Pfizer yields nearly 6%, while the iShares Biotechnology ETF has surged 27% in three months on takeover hopes.
Crowding Is Becoming The New Risk
Healthcare’s hot streak is starting to create a new risk of its own. Heavy call buying has followed sharp rallies in GE HealthCare Technologies and Medtronic, pushing put-call ratios (opens in a new tab) to levels that one options strategist says now flash sell signals for both stocks. The warning is a useful one for the broader rally, since even a strong sector can leave investors exposed when enthusiasm runs too far ahead of earnings.
- GE HealthCare climbed more than 12% in three months before put-call ratios flashed crowded optimism.
- Medtronic soared 26% since late May before options traders triggered another contrarian sell signal.
The rotation broadens: Healthcare is becoming a bigger part of Wall Street’s playbook beyond AI. Around 50 US-listed healthcare funds drew $2.44B (opens in a new tab) in July after nearly $1.5B in June, reversing three straight months of withdrawals. J.P. Morgan analysts called healthcare “a rare combination of durable growth, technology-like profitability, attractive valuation and diversification benefits.” So while the sector has momentum, selectivity matters more with every leg higher.
Sponsor
Your Portfolio Has a Forgotten-Subscription Problem
Remember that stock you bought five years ago? Of course you don't. It’s been sitting there collecting dust, and now you've got no idea what to do with it.
Here’s a trick: Get Finks to analyze your portfolio for free (opens in a new tab) (also judgment-free) and see where that money could be put to better use.
Finks is the financial assistant that helps you review your holdings, research investments, and reason through financial decisions.
- Understand your investments faster: Ask Finks to research any company (opens in a new tab), compare stocks, or get today's market moves explained in plain English.
- Agents that watch your money: Connect your holdings and watchlists, and let Finks keep an eye out for risks and opportunities around the clock.
Large-Cap Recap
Credit Stocks Take a Regulatory Hit
Washington is putting new pressure on the companies that profit from mortgage credit checks. FHFA Director Bill Pulte wants lenders to have broader access to VantageScore, giving them an alternative to FICO. He is also considering allowing lenders to pull two credit reports instead of the standard three. That could squeeze Fair Isaac through more competition while cutting report volume for Equifax, TransUnion, and Experian. Lenders may be slow to change established underwriting practices, making adoption the next key test. [Read (opens in a new tab)]
Agricultural Commodities Are Heating Up
Global food commodity prices are climbing as crop stress and export disruptions tighten supplies across grain and vegetable oil markets. Corn, wheat, and soybeans have all advanced amid extreme weather and Black Sea tensions. That rally has pushed the United Nations food price index up 1.9% in August. Investors looking for sector exposure can monitor agricultural funds such as the Invesco DB Agriculture Fund and agribusiness equities like Deere. [Read (opens in a new tab)]
The Cannabis Industry Finds Its Next Growth Market
Cannabis is breaking out of the dispensary as THC drinks find a place in mainstream retail. US sales reached $239M in the year through April, turning beverages into one of the industry’s clearest growth markets. Washington now holds the next catalyst. A temporary delay keeps hemp-derived THC products on shelves, while marijuana rescheduling could cut taxes for operators. Cannabis stocks remain volatile, but the industry is gaining new customers, new sales channels, and potentially a more favorable federal rulebook. [Read (opens in a new tab)]
Market Pulse
Bloom Energy Corporation
BEThe fuel-cell maker’s shares rose after its upcoming S&P 500 inclusion boosted expectations for fresh index-fund demand and investor interest.
Adobe Inc.
ADBEThe software maker’s shares fell after its CEO succession and a key executive’s departure raised fresh concerns about leadership and its AI strategy.
Lululemon Athletica Inc.
LULUThe athleisure retailer’s shares sank after falling sales and another full-year forecast cut deepened concerns about its struggling turnaround.
Markets & Economy
Job market runs hot as hiring rebounds: US employers added 162K jobs in August while the unemployment rate held steady at 4.1%. The stronger-than-expected payroll growth gives the Federal Reserve less cover to stay cautious at its upcoming meeting. [Read (opens in a new tab)]
US wage growth varies sharply by city and industry: Worker pay rose 4.7% nationally in August, but gains were much stronger in metros with tighter labor markets. Construction, finance and manufacturing posted some of the fastest wage growth. [Read (opens in a new tab)]
PC makers raise prices as shipments fall: HP, Dell and Lenovo are selling fewer computers but generating more revenue as memory shortages push prices higher. AI PCs are helping support demand, though consumers may increasingly resist premium pricing. [Read (opens in a new tab)]
Business & Tech
Personalized cancer vaccine trial drives sequencing demand: Moderna and Merck reported positive late-stage melanoma data for their custom mRNA therapy. BTIG estimates annual revenue could exceed $600M if the treatment expands to other cancers. [Read (opens in a new tab)]
Apple’s new CEO faces his first big product test: Apple will unveil new iPhones, Watches and its first foldable phone on Sept. 9. The launch will test whether John Ternus can turn new hardware categories into the company’s next growth engine. [Read (opens in a new tab)]
401(k) millionaires hit a record high: Fidelity says 769K retirement accounts now hold at least $1M, up 19% from the prior quarter. Strong markets and record employee contribution rates helped drive the surge, though most savers remain far below seven figures. [Read (opens in a new tab)]
Chart
Digit of the Day
Flat Cocktails Hit 38% of New Alcohol Launches
Big alcohol finally cracked the code on what Gen Z wants — and it's flat, not fizzy (opens in a new tab). Noncarbonated drinks swallowed up 38% of new premixed alcohol launches last year, up from 27% in 2021, as hard teas and vodka waters replace seltzers at bars. That pivot is already deciding which brewers and distillers ride alcohol’s only growth pocket.
- While the industry shrinks, ready-to-drink cocktail sales are surging — up 32% (opens in a new tab) this year, even as hard seltzers’ share sinks nearly 4%.
- For example, the rapid growth of Sun Cruiser is carrying (opens in a new tab) Boston Beer — masking softer demand for its Truly and Dogfish Head brands.
One last party: Boston Beer isn’t alone chasing the flat crowd. Gallo’s newly launched Lucky One Lemonade moved a million cases in its first seven months, beating the pace of the original High Noon. But that momentum masks industry-wide fatigue, as sits down by over 10% this year while alcohol names broadly trade like they’re bracing for structural decline (opens in a new tab). The pivot toward flat might be the industry’s clearest growth lever, but so far it’s cushioning the decline more than ending it.
Post Credits
Sponsor
The Trick To Managing Your Stock Watchlists Better
Traditional watchlists are a nightmare to manage. Add one stock here, another there, and suddenly you're staring at a hundred names you never actually look at.
The solution: Let Finks, your new financial assistant, watch the list for you.
Just keep adding stocks, or get Finks to build watchlists for you (opens in a new tab). Then try asking questions like: "Which stocks on my watchlist look most interesting right now?"
A hundred stocks is only unmanageable if you're the one managing them.